Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Pfizer
Business Segments
Products & Services
Indefinite-lived intangible assets, period increase (decrease)
Indefinite-lived intangible assets, period increase (decrease)
Pfizer
·
Products & Services
·
2 segments
·
Rolls up to
Indefinite Lived Intangible Assets Period Increase Decrease
Breakdown
Segments
Tukysa
View metric
Padcev
View metric
Quarterly
Annual
TTM
Segment
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Tukysa
—
—
—
—
-$580M
Padcev
-$150M
-$150M
-$150M
-$150M
—
Total
—
—
—
—
—
Padcev is derived from annual filings.